EGFLAM-AS3

Across TCGA pan-cancer cohorts, EGFLAM-AS3 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated EGFLAM-AS3 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher EGFLAM-AS3 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated EGFLAM-AS3 expression acts as an unfavorable survival marker, although some lineages such as KIRC show a favorable association.

STAD, KIRP, and ACC are the cancer types where EGFLAM-AS3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.327	0.583	<.001	111	view →
KIRP	OS	Tertile	All	0.453	0.887	<.001	90	view →
ACC	DFS	Tertile	All	0.046	0.753	<.001	72	view →
UCEC	OS	Tertile	III,IV	0.597	0.834	.004	42	view →
SKCM	DFS	Tertile	All	0.058	0.757	<.001	27	view →
TGCT	OS	Tertile	All	0.817	0.968	.021	18	view →
LIHC	DFS	Tertile	II,III,IV	0.020	0.427	<.001	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
KIRC	DFS	Tertile	All	0.962	0.867	.047	6	view →
PCPG	DFS	Tertile	All	0.447	0.865	.044	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

EGFLAM-AS3–STAD (DFS)

Open the STAD breakdown →